Live Breaking News & Updates on Responsive Patients

Stay updated with breaking news from Responsive patients. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ipsen to present new Bylvay® (odevixibat) data at annual ESPGHAN congress, showcasing commitment to furthering treatment for rare cholestatic liver diseases

Six abstracts to be presented demonstrating efficacy and tolerability of investigational Bylvay in select cholestatic liver diseasesNew data emphasizes the consistent benefit of Bylvay as an. | May 17, 2023 ....

France General , City Of , United Kingdom , United States , Georg Friedrich Vogel , Amy Wolf , Anna Gibbins , Nadia Ovchinsky , Nicolas Bogler , Intrahepatic Cholestasis , Ipsen Euronext , Richardj Thompson , Mark Nomden , Howard Mayer , Asia Pacific , Tassos Grammatikopoulos , Ioana Piscociu , Grossman School Of Medicine , Institute Of Cell Biology , University Medical Center Groningen , Head Of Research , Institute Of Liver , University Of Innsbruck , King College London , Department Of Pediatrics , Head Of Corporate Brand Strategy Communications ,

Ipsen Pharma: Ipsen to present new Bylvay® (odevixibat) data at annual ESPGHAN congress, showcasing commitment to furthering treatment for rare cholestatic liver diseases

Six abstracts to be presented demonstrating efficacy and tolerability of investigational Bylvay in select cholestatic liver diseasesNew data emphasizes the consistent benefit of Bylvay as an investigational ....

France General , United States , City Of , United Kingdom , Howard Mayer , Richardj Thompson , Nadia Ovchinsky , Tassos Grammatikopoulos , Georg Friedrich Vogel , Amy Wolf , Anna Gibbins , Ipsen Euronext , Intrahepatic Cholestasis , Ioana Piscociu , Asia Pacific , Mark Nomden , Nicolas Bogler , Gewinn Nur , University Of Innsbruck , Grossman School Of Medicine , Institute Of Liver , University Of Groningen , Institute Of Cell Biology , Albireo Pharma Inc , King College London , Department Of Pediatric Surgery ,

Bylvay® (odevixibat) Data Presented at AASLD The Liver Meeting® 2022, Demonstrating Native Liver Survival in Children Across PFIC Types

Early, rapid, and sustained efficacy across wide range of patients with evidence of disease modificationLong-term preservation of native liver in PFIC, improvements in pruritus, bile acids, and. | November 7, 2022 ....

United States , United Kingdom , Northern Ireland , City Of , Vastra Gotalands Lan , Henkjanj Verkade , Colleen Alabiso , Erik Lindstr , Lorenzo Dantiga , Lance Buckley , Mark Nomden , Richard Thompson , Richardj Thompson , Hans Vitzthum , Jan Mattsson , Nadia Ovchinsky , Intrahepatic Cholestasis , Azienda Ospedaliera Papa Giovanni , Asia Pacific , Georg Friedrich Vogel , King College London , Department Of Paediatric Hepatology , University Of Groningen , Globenewswire Inc , Albireo Pharma Inc , Lifesci Advisors ,